Cardiovascular disease (CVD) accounts for approximately one-third of all global deaths, and
acute coronary syndrome (ACS) is the most severe form of CVD. It is of notable importance …

Background Successful implementation of practice guidelines has been challenging in the
treatment of acute coronary syndrome (ACS), leaving room for improvement. A nationwide …

Scarce and conflicting evidence exists on whether clopidogrel is effective and whether dual
antiplatelet treatment (DAPT) is safe in patients with acute coronary syndrome and chronic …

Background Diabetes mellitus (DM) is a major public health problem in Taiwan and is
associated with poor outcomes in patients with coronary artery disease. However, the role of …

Background Mechanisms of accelerated atherothrombosis in patients with chronic kidney
disease (CKD) are only partly characterized. The aims of this study were to evaluate the …

The pathogenesis of cardiovascular disease in CKD differs subtly from that of non-CKD
patients. As renal function declines, the role and impact of treating classical risk factors may …

Гломерулонефриты представляют основной раздел современной нефрологии в
терапевтической клинике. В группе заболеваний почек и мочевыводящих путей …

Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a
Background of Aspirin (PEGASUS-TIMI 54) trial had an eGFR< 60 mL/min/1.73 m2 (11) …

Antiplatelet is the cornerstone therapy for patient with coronary artery disease. Several
comorbidities can influence the efficacy and safety of antiplatelet agent. Diabetes mellitus is …

A recently published article by Lai et al. 1 in Acta Cardiologica Sinica evaluated the outcome
of patients with acute coronary syndrome (ACS) who were treated with a bare metal stent …